NeuroGo uses Neuromuscular Electrical Stimulation (NMES), a technology backed by decades of peer-reviewed research showing significant benefits for neuropathy and circulation.
Reduction in pain scores with electrical stimulation therapy
Improvement in sleep quality for neuropathy patients
Average time to significant symptom improvement
Patients reporting improved quality of life
A comprehensive study published in the Journal of Diabetes Science and Technology examined the effects of electrical stimulation on painful diabetic neuropathy. Researchers found that patients using electrical stimulation therapy experienced an average 87% reduction in pain scores after 6 weeks of treatment.
How this supports NeuroGo: This study directly validates NeuroGo's approach of using electrical stimulation to manage neuropathic pain. The dramatic pain reduction seen in clinical settings mirrors what many NeuroGo users report.
Thakral G, et al. "Electrical Stimulation as an Adjunctive Treatment of Painful and Sensory Diabetic Neuropathy." J Diabetes Sci Technol. 2013.German researchers demonstrated that high-frequency external muscle stimulation significantly improved symptoms in patients with diabetic polyneuropathy. The study showed improvement in both sensory symptoms and pain levels.
How this supports NeuroGo: NeuroGo's multiple frequency modes allow users to find the optimal stimulation pattern for their needs, similar to the high-frequency approach validated in this research.
Reichstein L, et al. "Effective treatment of symptomatic diabetic polyneuropathy by high-frequency external muscle stimulation." Diabetologia. 2005.A clinical trial found that external electric muscle stimulation improved burning sensations by 75% and sleeping disturbances by 73% in type 2 diabetes patients with symptomatic neuropathy.
How this supports NeuroGo: Many NeuroGo users report better sleep after using the device before bedtime, which aligns perfectly with these clinical findings about improved sleep quality.
Humpert PM, et al. "External electric muscle stimulation improves burning sensations and sleeping disturbances." Diabetes Care. 2009.Research has identified abnormal blood flow patterns as a key factor in diabetic neuropathy pain. Studies show that improving circulation can significantly reduce neuropathic symptoms.
How this supports NeuroGo: NeuroGo's muscle stimulation creates a pumping action that enhances blood flow to the feet, addressing the circulation problems identified in this research.
Archer AG, et al. "Blood flow patterns in painful diabetic neuropathy." Lancet. 1984.Harvard Medical School researchers explored how improving vascular function through growth factors can reverse neuropathy symptoms, demonstrating the critical link between circulation and nerve health.
How this supports NeuroGo: Electrical stimulation has been shown to increase production of vascular growth factors, supporting the body's natural healing processes that NeuroGo helps activate.
Veves A, King GL. "Can VEGF reverse diabetic neuropathy in human subjects?" J Clin Invest. 2001.Danish researchers demonstrated that capillary dysfunction leads to poor oxygen and glucose delivery in diabetic neuropathy, and that improving microcirculation can restore nerve function.
How this supports NeuroGo: By stimulating muscles and improving local circulation, NeuroGo helps deliver more oxygen and nutrients to damaged nerves, supporting the healing process described in this research.
Østergaard L, et al. "The effects of capillary dysfunction on oxygen and glucose extraction in diabetic neuropathy." Diabetologia. 2015.Italian researchers found that frequency-modulated electromagnetic neural stimulation was effective in 92% of patients with painful diabetic neuropathy, with significant improvements in quality of life scores.
How this supports NeuroGo: NeuroGo's different frequency modes allow users to find their optimal setting, similar to the frequency modulation approach that achieved such high success rates in this study.
Bosi E, et al. "Effectiveness of frequency-modulated electromagnetic neural stimulation." Diabetologia. 2005.A comprehensive review of electrotherapy for diabetic peripheral neuropathy found that 85% of patients experienced significant symptomatic relief, with improvements lasting beyond the treatment period.
How this supports NeuroGo: This broad effectiveness across multiple studies validates NeuroGo's approach and explains why so many users experience lasting relief with consistent use.
Kumar D, et al. "Diabetic peripheral neuropathy. Effectiveness of electrotherapy for symptomatic relief." Diabetes Care. 1998.University of Texas researchers demonstrated that percutaneous electrical nerve stimulation provided rapid and sustained pain relief for diabetic neuropathy patients, with effects beginning within the first week of treatment.
How this supports NeuroGo: Many NeuroGo users report feeling relief within the first week, consistent with the rapid response times documented in this clinical research.
Hamza MA, et al. "Percutaneous electrical nerve stimulation: a novel analgesic therapy." Diabetes Care. 2000.Recent 2024 research highlights the severe impact of untreated neuropathy, with patients facing significantly increased amputation risk. Early intervention with effective treatments dramatically improves quality of life outcomes.
How this supports NeuroGo: By providing an accessible, at-home treatment option, NeuroGo helps users take proactive steps to manage their neuropathy before it progresses to more serious complications.
Perveen W, et al. "Prevalence of peripheral neuropathy, amputation, and quality of life in patients with diabetes." Int J Environ Res Public Health. 2024.A randomized controlled trial demonstrated that electrical stimulation techniques provided sustained improvements in neuropathy symptoms, with benefits continuing months after treatment.
How this supports NeuroGo: This research supports NeuroGo's recommendation for consistent daily use, showing that regular stimulation creates lasting positive changes in nerve function.
Sahba K, et al. "Treating peripheral neuropathy in individuals with type 2 diabetes." J Int Med Res. 2022.Based on decades of research, NMES technology works through several proven mechanisms:
Electrical impulses activate nerve fibers, promoting the production of nerve growth factors and supporting regeneration of damaged nerves.
Rhythmic muscle contractions create a pumping effect that enhances blood flow, delivering oxygen and nutrients while removing metabolic waste.
Non-painful electrical signals override pain messages at the spinal cord level, providing immediate relief while healing occurs.
Increased cellular ATP production and improved glucose uptake help restore normal nerve function and reduce inflammation.
NMES has been studied for decades with consistent positive results for neuropathy relief
Clinical studies show 73-92% of patients experience significant improvement
NeuroGo brings clinically-proven technology into your home for daily use
Join thousands who have found relief with NeuroGo's research-backed technology.
Disclaimer: These studies represent independent research on NMES technology. While NeuroGo uses similar technology, individual results may vary. Always consult with your healthcare provider before starting any new treatment. NeuroGo is not intended to diagnose, treat, cure, or prevent any disease. Read more about NeuroGo on our FAQ page.